Launched in summer of 2017, the Philips Wearables Challenge called for novel solutions to predict early signs of patient deterioration and prevent hospital readmission. Forty teams from across the country submitted their cutting edge technologies and systems to facilitate early, appropriate interventions.
Congratulations to the six finalists selected by a combination of your crowd votes and the evaluations of our expert panel of judges. These six finalists will battle it out on stage at The Martin Center at Harvard Medical School on October 26 at 6:30pm. A cocktail & hors d’oeuvres reception will begin at 5:30pm. For tickets, click here.
The six finalist teams are:
Raiing Medical: Raiing Medical develops connected health solutions based on the wearable technology. Our goal is to identify vital signs patterns for disease diagnosis, management, prediction, and prevention.
Bold Diagnostics: Current blood pressure measurement technologies fail to produce continuous and accurate clinical results that are required to diagnose and treat hypertension. BOLD has developed a robust, patent pending method of measuring blood pressure known as differential pulse arrival time (DPAT), which is both non-invasive and continuous. The technology was designed to leverage the power of AI and the proliferation of ppg sensors in the consumer wearable market.
Nanowear: Nanowear is a connected-self technology platform for diagnostics and chronic disease management. Utilizing its proprietary, FDA 510(k) cleared, cloth-based nanosensors, Nanowear has developed its first product, SimpleSense, which transforms Congestive Heart Failure (CHF) management by non-invasively alerts of decompensating heart failure weeks in advance of a hospitalizing event.
Helbling Precision Engineering: An independent R&D contractor with a passion for developing medical devices and laboratory instruments, we support clients from idea inception through to market launch. Our vision-Innovation, together we do it-is based on the belief that innovation is key to success and profoundly shapes our entrepreneurial culture.
Leuko Labs: Daily non-invasive testing for early identification of chemotherapy patients with dangerously low levels of white blood cells.
HealthyAge: HealthyAge is an integrated smart-home system for patient deterioration and hospital readmission prevention. Utilising a mixture of select smart devices, including smart wearable glasses, wrist-wearable device, toilet add-ons and smart bed-sheets, HealthyAge captures data in real time to provide both users, caretakers and health professionals meaningful health prevention data.
Congratulations again to our six finalists! We look forward to seeing you on October 26th!
Abby Ballou is the managing editor of MedTech Boston. She has a B.A. and M.Phil in English literature from NYU and the CUNY Graduate Center, respectively. When she isn’t writing and editing for MedTech Boston, Abby enjoys reading, rock climbing, watching classic movies and listening to opera.
Send this to a friend